Drugmaker revives obesity pill rejected by FDA
By MATTHEW PERRONE , 09.20.11, 06:22 PM EDT WASHINGTON — Orexigen Therapeutics Inc. said Tuesday it is reviving its previously abandoned weight loss drug Contrave, after federal health officials outlined a plan that could bring the drug to market by …
See all stories on this topic »